产品名称
ERK5,活性,GST 标记 人, PRECISIO® Kinase, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution
biological source
human
recombinant
expressed in baculovirus infected Sf9 cells
product line
PRECISIO® Kinase
assay
≥70% (SDS-PAGE)
form
buffered aqueous glycerol solution
specific activity
9.4-12.7 nmol/min·mg
mol wt
~132 kDa
NCBI accession no.
application(s)
cell analysis
shipped in
dry ice
storage temp.
−70°C
Gene Information
human ... MAPK7(5598)
Physical form
Supplied in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol.
Preparation Note
after opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles
Legal Information
PRECISIO is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
C1q-TNF-related protein-9 promotes cardiac hypertrophy and failure
Mahesh Appari
Circulation Research (2016)
ERK5 Mediated Signalling in Diabetic Retinopathy
Yuexiu Wu
Medical Hypotheses (2015)
MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma.
Tesser-Gamba F
Molecular Carcinogenesis (2016)
Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma
Paul R. Gavine
BMC Cancer (2015)
Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects
Christopher
Proceedings of the National Academy of Sciences of the USA (2002)
相关内容
Instructions
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持